Career history of Gwynfor Owen Humphreys
Former positions of Gwynfor Owen Humphreys
| Companies | Position | Start | End |
|---|---|---|---|
| AVACTA GROUP PLC | Director/Board Member | 2006-07-12 | 2015-01-22 |
| Chairman | 2010-12-23 | 2014-01-23 | |
| GUNSYND PLC | Director/Board Member | 2004-09-30 | 2014-09-14 |
| Chief Executive Officer | 2012-05-02 | 2014-09-14 | |
Nektar Therapeutics UK Ltd.
 Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Founder | 1995-11-30 | 2000-12-31 |
| President | 1995-11-30 | 2000-12-31 | |
SolAeroMed, Inc.
 SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Director/Board Member | - | - |
Statistics
International
| United Kingdom | 4 |
| Canada | 2 |
Operational
| Director/Board Member | 3 |
| Chairman | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| AVACTA GROUP PLC | Commercial Services |
| GUNSYND PLC | Health Technology |
| Private companies | 2 |
|---|---|
Nektar Therapeutics UK Ltd.
Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Health Technology |
SolAeroMed, Inc.
SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Health Technology |
